Toronto Expansion to Create Jobs and Boost Province’s Innovation Economy
TORONTO — The Ontario government says a $294 million investment by Sanofi to expand its Artificial Intelligence Centre of Excellence (AI CoE) in Toronto will strengthen the province’s position as a global leader in life sciences and artificial intelligence, while creating new high-skilled jobs.
The expansion is expected to generate 50 new positions, adding to an existing workforce of more than 150 employees at the company’s AI-focused research hub. The investment underscores Ontario’s ongoing efforts to attract multinational companies and scale its innovation economy amid intensifying global competition for talent and capital.
Premier Doug Ford said the announcement highlights confidence in the province’s workforce and technology ecosystem.
“Our government is proud to welcome this exciting new investment and to support Sanofi as they continue expanding their footprint here in Ontario,” said Premier Doug Ford. “Today’s announcement is a clear demonstration of Sanofi’s confidence in our world-class STEM workers and ensures they will continue to play a central role as we make Ontario a global hub for the development of cutting-edge technologies.”
Strategic Focus on AI and Life Sciences Growth
The project will expand Sanofi’s capabilities in artificial intelligence, machine learning and pharmaceutical data science, with a focus on accelerating drug discovery and vaccine development. The company is expected to leverage Ontario’s deep talent pool, including a steady pipeline of STEM graduates, to support its research and development operations.
The province is contributing up to $5 million through Invest Ontario, aligning the project with its broader life sciences strategy aimed at increasing domestic capacity and innovation.
“Sanofi’s investment is a testament to Ontario’s leadership in the AI and life sciences sectors, reinforcing our reputation as the best place to innovate, scale and succeed,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “We look forward to seeing Sanofi continue to grow in the province, creating good-paying jobs for our workers and producing essential medicines and vaccines for Canada and the world.”
The expansion will also include partnerships with Ontario universities, offering internship opportunities designed to build the next generation of AI and life sciences talent.
Building on Toronto’s Role as a Global AI Hub
Sanofi first selected Toronto as the location for its global AI Centre of Excellence in 2022 following an international review, citing the region’s strong digital infrastructure and access to specialized talent. The company has since deepened its presence in Ontario, including the opening of Canada’s largest biomanufacturing facility in North York in 2024.
“Today’s announcement reinforces Sanofi’s long-term commitment to investing in and growing the AI talent pipeline in Toronto and strengthening Ontario’s position as a strategic hub for innovation,” said Dimitrije Jankovic, Global Head of Digital Strategy and Operations at Sanofi. “As the first AI-powered, R&D-driven biopharma, Sanofi is focused on getting life-changing medicines to patients faster than ever before, and we are grateful for the partnership with the province of Ontario in driving this innovation.”
Ontario officials say the province’s life sciences sector generated more than $86 billion in revenue in 2024, making it the largest in Canada. The region also produces more than 94,000 STEM graduates annually and has become a leading centre for AI education and research.
Economic Impact and Workforce Development
Government data shows Ontario has attracted more than $222 billion in investment since 2018, creating approximately one million new jobs. Officials say policies aimed at reducing regulatory burdens and lowering business costs — estimated to save companies $12 billion annually — have contributed to sustained investment flows.
The Sanofi expansion is expected to further strengthen Ontario’s competitiveness in both the digital and health-care sectors, while supporting domestic vaccine production and global pharmaceutical innovation.
“Sanofi’s Artificial Intelligence Centre of Excellence expansion advances technologies that can transform patient outcomes and enhance our health-care system. This investment will create long term economic opportunity while delivering tangible health benefits for families across the province and the country, including support for life sciences work that enables Sanofi to protect millions of Canadians from infectious disease through vaccine production, alongside other innovative research and development initiatives,” said Sylvia Jones, Deputy Premier and Minister of Health.
AI Investment Seen as Key to Competitiveness
Provincial officials emphasized that artificial intelligence will play a central role in economic growth and productivity, particularly in sectors such as health care, manufacturing and logistics.
“Artificial intelligence is reshaping the global economy, and Ontario is well positioned to lead. Investments like this help ensure Ontario companies, workers and researchers have the secure digital infrastructure, strong talent base and responsible innovation environment they need to compete and succeed. By supporting AI growth with the right safeguards in place, our government is strengthening Ontario’s competitiveness and digital resilience,” said Stephen Crawford, Minister of Public and Business Service Delivery and Procurement.
Education and workforce readiness were also highlighted as key components of the province’s strategy.
“Ontario is producing nearly 100,000 highly skilled STEM graduates every single year who protect our key industries and drive our economy. Sanofi’s expansion of its AI Centre of Excellence will launch our graduates into good-paying careers and ensure Ontario stays on the cutting edge of innovation,” said Nolan Quinn, Minister of Colleges, Universities, Research Excellence and Security.
Municipal and Industry Support
Toronto Mayor Olivia Chow welcomed the investment, citing the city’s growing reputation as a global centre for technology and life sciences.
“Toronto is proud to welcome this new investment from Sanofi. Our world-class AI talent, strong life sciences sector and dynamic innovation community make Toronto a natural destination for companies that want to grow and lead. We look forward to seeing Sanofi continue to expand and contribute to the strength of our city and to better health outcomes for people here and around the world.”
Industry leaders also pointed to the broader implications for Ontario’s innovation ecosystem.
“Sanofi’s decision to expand its global AI Centre of Excellence in Toronto is a strong endorsement of Ontario’s leadership in artificial intelligence and digital innovation. Ontario offers a rare combination of world-class AI talent, advanced digital infrastructure and deep life sciences expertise. We are proud to support Sanofi as it brings global AI leadership roles to the province and creates high-skilled jobs that strengthen Ontario’s position as a hub for enterprise-scale innovation,” said Khawar Nasim, CEO of Invest Ontario.
Outlook
The investment is expected to reinforce Ontario’s standing as a leading destination for life sciences and AI development, while supporting job creation and long-term economic growth. As global demand for advanced health technologies rises, projects like Sanofi’s expansion highlight the province’s strategy to position itself at the intersection of digital innovation and health care.